Radiolysis, Photolysis, Sonolysis and Sonoprotection of Cells and their Constitu

细胞及其成分的放射分解、光分解、声分解和声保护

• 批准号: 7594761
• 负责人: PETER RIESZ
• 金额: $ 49.97万
• 依托单位: DIVISION OF CLINICAL SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/7594761
• 关键词: Adverse effects; Aminolevulinic Acid; Anabolism; Apoptosis; Biological; Biology; Cancer Science; Carbon; Cells; Cellular Membrane; Chemicals; Citrate; Citrates; Clinical Trials; Condition; Cultured Cells; Cytolysis; Development; Drug Delivery Systems; Equilibrium; Event; Focused Ultrasound Therapy; Free Radicals; Frequencies; Gases; Gene Expression; Gene Transfer; Glucose; Gold; HL-60 Cells; HL60; Hydrogen; Hydrogen Peroxide; Hydroxyl Radical; In Vitro; Induction of Apoptosis; International; Japan; Journals; Lead; Light; Lipid Peroxidation; Liquid substance; MCF7 cell; Measurement; Medicine; Methods; Modality; Molecular; Oxygen; Pharmaceutical Preparations; Photochemotherapy; Porphyrins; Probability; Property; Radiobiology; Range; Reaction; Research; Series; Site; Solutions; Staging; Surface; System; Therapeutic; Tissues; U937 Cells; Ultrasonic Therapy; Ultrasonics; Ultrasonography; Water; Work; absorption; alkoxyl radical; base; cancer therapy; cell killing; drug mechanism; gene therapy; interest; killings; methyl beta-D-glucopyranoside; nanoparticle; perhydroxyl radical; photolysis; prevent; protective effect; protoporphyrin IX; size; sonoporation; surfactant; tumor

Summary of work: Sonodynamic therapy is a promising new modality for cancer treatment based on the synergistic effects of cell killing by a combination of sonosensitizer and ultrasound. Ultrasound can penetrate deeply into tissue and can be focused in a small region of tumor to activate non-toxic molecules (e.g. porphyrins ) thus minimizing undesirable side effects. The experimental evidence suggests that sonosensitization is due to the chemical activation of sonosensitizers inside or in close vicinity of hot collapsing cavitation bubbles to form sensitizer-derived radicals either by direct pyrolysis of the sensitizer at the water-gas interface or due to the reactions of hydrogen atoms and hydroxyl radicals formed by the pyrolysis of water. The free radicals derived from the sonosensitizer (mostly carbon-centered) react with oxygen to form peroxyl and alkoxyl radicals. Unlike OH radicals and H atoms which are formed by pyrolysis inside cavitation bubbles, the reactivity of alkoxyl and peroxyl radicals with organic compounds in biological media is much lower and hence they have a higher probability of reaching critical cellular sites. Our recent studies have shown that the long chain ( C5-C8 ) n-alkyl glucopyranosides completely inhibit ultrasound induced cytolysis (3). This protective effect has possible applications in HIFU ( High intensity focused ultrasound ) for tumor treatment and in ultrasound assisted drug delivery and gene therapy. n-Alkyl glucopyranosides with hexyl ( 5mM ), heptyl ( 3mM ), octyl ( 2mM ) n-alkyl chains protected 100 % of HL-60 cells in vitro from 1.057 MHz ultrasound induced cytolysis under a range of conditions which resulted in 35% to 100% cytolysis in the absence of glucopyranosides. However the hydrophilic methyl-beta-D-glucopyranoside did not protect cells. The surface active n-alkyl glucopyranosides accumulate at the gas-liquid interface of cavitation bubbles. The OH radicals and H atoms formed in collapsing cavitation bubbles react by H-atom abstraction from either the n-alkyl chain or the glucose moiety of the n-alkylglucopyranosides. Owing to the high concentration of the long chain surfactants at the gas-liquid interface of cavitation bubbles , the initially formed carbon radicals on the alkyl chains are transferred to the glucose moieties to yield radicals which react with oxygen leading to the formation of hydrogen peroxide. Our recent measurements (2) of the hydrogen peroxide yields at 614 kHz and 1.057 MHz from oxygen-saturated solutions of long chain ( hexyl , octyl ) glucopyranosides compared with methyl-beta-D-glucopyranoside are consistent with the proposed mechanism of sonoprotection. This sequence of events prevents sonodynamic cell killing by initiation of lipid peroxidation chain reactions in cellular membranes by peroxyl and/or alkoxyl radicals. The effect of ultrasound frequency (from 47 kHz to 1 MHz ) on the ability of a homologous series of n-alkylglucopyranosides to protect cells from ultrasound-induced cytolysis was investigated. Comparisons of the protective ability of this series of n-alkylglucopyranosides with our earlier studies of their accumulation at the gas/solution interface of cavitation bubbles show that the ability of these surfactants to accumulate at this gas/solution interface is governed by the dynamic absorption properties and not the equilibrium absorption properties of these surfactants. Therapeutic applications of ultrasound to drug activation, apoptosis induction, gene transfer and changes of gene expression were reviewed (1). 5-Aminolevulinic acid ( a precursor for the biosynthesis of protoporphyrin IX which is used in photodynamic therapy ) combined with intracellular citrate capped gold nanoparticles of specific sizes ( e.g. 5nm ) was found to be effective in killing cultured cells ( HL-60, HL-525 and MCF-7 ) even in the absence of light. 1. Yoshida,T., Kondo, T., Ogawa, R., Zhao, Q., Hassan, M., Watanabe, A., Takasaki, I., Tabuchi, Y., Shoji, M., Kudo, N., Feril, L., Tachibana, K., Buldakov, M., Honda, T., Tsukada, K.& Riesz, P., Molecular therapy by ultrasound. The mechanism of drug activation, apoptosis induction, gene transfer, and change of gene expressions. Thermal Medicine ( Japan), (2007) in press 2. Cheng, J.Y. & Riesz, P., Mechanism of the protective effects of long chain n-alkyl glucopyranosides against ultrasound-induced cytolysis of HL-60 cells. Ultrasonics Sonochemistry 14, 667-671 (2007) 3. Sostaric, J.Z., Miyoshi, N., Riesz, P., De Graff, W.G. & Mitchell, J.B., n-Alkyl glucopyranosides completely inhibit ultrasound-induced cytolysis. Free Radical Biology & Medicine 39, 1539-1548, (2005) 4.. Feril, L.B., Tsuda, Y., Kondo, T., Zhao, Q.L., Ogawa, R., Cui, Z.G., Tsukada, K. & Riesz P., Ultrasound-induced killing of monocytic U937 cells enhanced by 2,2'-azobis(2-amidinopropane) dihydrochloride. Cancer Science 95, 181-185 (2004). 5.. Feril, L., Kondo, T., Takaya, K. & Riesz, P., Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. International Journal of Radiation Biology 80, 165-175 (2004). 6.. Rosenthal, I., Sostaric, J. & Riesz, P., Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrasonics Sonochemistry 11, 349-363 (2004). 7.. Rosenthal, I., Sostaric, J. & Riesz, P., Enlightened sonochemistry. Research on Chemical Intermediates 30, 685-701 (2004)

工作总结：声动力疗法是一种有前途的癌症治疗新方式，基于声敏剂和超声波组合杀伤细胞的协同效应。超声波可以深入渗透到组织中，并可以聚焦在肿瘤的小区域，以激活无毒分子（例如卟啉），从而最大限度地减少不良副作用。实验证据表明，声敏化是由于热塌陷空化气泡内部或附近的声敏剂的化学活化，通过敏化剂在水-气界面的直接热解或由于水热解形成的氢原子和羟基自由基的反应而形成敏化剂衍生的自由基。源自声敏剂的自由基（大部分以碳为中心）与氧反应形成过氧自由基和烷氧基自由基。与空化气泡内热解形成的 OH 自由基和 H 原子不同，烷氧基和过氧自由基与生物介质中有机化合物的反应性要低得多，因此它们更有可能到达关键细胞位点。我们最近的研究表明，长链 (C5-C8) n-烷基吡喃葡萄糖苷完全抑制超声诱导的细胞溶解 (3)。这种保护作用可能应用于肿瘤治疗的 HIFU（高强度聚焦超声）以及超声辅助药物输送和基因治疗。具有己基 (5mM)、庚基 (3mM)、辛基 (2mM) 正烷基链的正烷基吡喃葡萄糖苷可在体外保护 100% 的 HL-60 细胞免受 1.057 MHz 超声诱导的细胞溶解作用，在一系列条件下，在没有吡喃葡萄糖苷的情况下导致 35% 至 100% 的细胞溶解。然而，亲水性的甲基-β-D-吡喃葡萄糖苷并不能保护细胞。表面活性的正烷基吡喃葡萄糖苷在空化气泡的气液界面处积聚。 OH自由基和空化气泡中形成的H原子通过从正烷基吡喃葡萄糖苷的正烷基链或葡萄糖部分夺取H原子而发生反应。由于空化气泡的气液界面处长链表面活性剂的浓度较高，烷基链上最初形成的碳自由基转移到葡萄糖部分，产生自由基，自由基与氧反应，导致过氧化氢的形成。我们最近对长链（己基、辛基）吡喃葡萄糖苷的氧饱和溶液在 614 kHz 和 1.057 MHz 下的过氧化氢产量的测量 (2) 与甲基-β-D-吡喃葡萄糖苷相比，与所提出的声波保护机制一致。这一系列事件通过过氧自由基和/或烷氧基自由基在细胞膜中引发脂质过氧化链反应来防止声动力学细胞杀伤。研究了超声频率（从 47 kHz 到 1 MHz）对同源系列正烷基吡喃葡萄糖苷保护细胞免受超声诱导的细胞溶解的能力的影响。将这一系列正烷基吡喃葡萄糖苷的保护能力与我们早期对其在空化气泡的气体/溶液界面上的积累的研究进行比较表明，这些表面活性剂在该气体/溶液界面上的积累能力是由动态吸收特性决定的，而不是这些表面活性剂的平衡吸收特性。对超声在药物激活、细胞凋亡诱导、基因转移和基因表达变化方面的治疗应用进行了综述(1)。 5-氨基乙酰丙酸（用于光动力疗法的原卟啉 IX 生物合成的前体）与特定尺寸（例如 5nm）的细胞内柠檬酸盐封端的金纳米颗粒相结合，即使在没有光的情况下也能有效杀死培养细胞（HL-60、HL-525 和 MCF-7）。 1. Yoshida,T.、Kondo, T.、Okawa, R.、Zhao, Q.、Hassan, M.、Watanabe, A.、Takasaki, I.、Tabuchi, Y.、Shoji, M.、Kudo, N.、Feril, L.、Tachibana, K.、Buldakov, M.、Honda, T.、Tsukada, K.& Riesz, P.，分子治疗 超声波。药物激活、细胞凋亡诱导、基因转移和基因表达变化的机制。热医学（日本），（2007 年）出版 2。 Cheng, J.Y. & Riesz, P.，长链正烷基吡喃葡萄糖苷对超声诱导的 HL-60 细胞细胞溶解的保护作用机制。 Ultrasonics Sonochemistry 14, 667-671 (2007) 3. Sostaric, J.Z.、Miyoshi, N.、Riesz, P.、De Graff, W.G. 和 Mitchell, J.B.，正烷基吡喃葡萄糖苷完全抑制超声诱导的细胞溶解。自由基生物学与医学 39, 1539-1548, (2005) 4.. Feril, L.B.、Tsuda, Y.、Kondo, T.、Zhao, Q.L.、Okawa, R.、Cui, Z.G.、Tsukada, K. 和 Riesz P.，超声诱导的单核 U937 细胞杀伤增强 2,2'-偶氮二(2-脒基丙烷)二盐酸盐。癌症科学 95, 181-185 (2004)。 5.. Feril, L.、Kondo, T.、Takaya, K. 和 Riesz, P.，低渗介质增强超声诱导的细胞凋亡和细胞裂解。国际放射生物学杂志 80, 165-175 (2004)。 6.. Rosenthal, I.、Sostaric, J. 和 Riesz, P.，声动力学疗法 - 药物和超声协同作用的综述。超声波声化学 11, 349-363 (2004)。 7.. Rosenthal, I.、Sostaric, J. 和 Riesz, P.，Enlightened 声化学。化学中间体研究 30, 685-701 (2004)